Pregnancy
|
Weeks
|
Ultrasonography
|
Venapunction
|
Questionnaires
|
14 | S, C1, C2 | S, C1, C2 | S, C1, C2 * |
20 | S | | S, C1, C2 * |
26 | S | | S, C1, C2 * |
32 | S | S, C1, C2 | S, C1, C2 * |
38 | S | | S, C1, C2 * |
Post-partum
|
Weeks
|
Ultrasonography
|
Venapunction
|
Questionnaires
|
6 | S | | S, C1, C2 * |
12 | S | | S, C1, C2 * |
- S, study group; C1 control group 1 (healthy pregnant patients without HCA); C2, control group 2 (pregnant patients with Diabetes Mellitus).
- *The study group will be asked to fill out the SF-12, EQ-5d, STAI-6 and IES questionnaires before and one week after US of the HCA lesion(s). Both control groups will be asked to fill out the SF-12 and EQ-5d questionnaire.
